Trials / Completed
CompletedNCT04297384
Breast Cancer Pathways Program Impact on Patient Shared Decision Making and Experience in Academic and Community Practice
Breast Cancer Pathways Impact on Patient Shared Decision Making and Experience in Academic and Community Practice
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 174 (actual)
- Sponsor
- Roswell Park Cancer Institute · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This trial studies the impact of the breast cancer pathways program on the patient experience, including decision making and quality of life. Measuring how the breast cancer pathways program affects decision making and quality of life in patients may help doctors improve cancer education.
Detailed description
PRIMARY OBJECTIVES: I. Evaluate the impact of breast cancer pathways on patient experience, burden of decision making and quality of life in tertiary cancer center and community oncology practice. II. Identify modifiable factors that affect provider adoption of breast cancer pathways in tertiary cancer center and community oncology practice. OUTLINE: Participants are assigned to 1 of 2 groups. GROUP I: Participants receive standard chemotherapy educational materials. Participants also complete surveys over approximately 22 minutes at the time of first chemotherapy infusion, and approximately 8 weeks after first chemotherapy infusion. GROUP II: Participants receive personalized information about their cancer, treatment, and side effects. Participants also complete surveys over approximately 22 minutes at the time of first chemotherapy infusion, and approximately 8 weeks after first chemotherapy infusion.
Conditions
- Anatomic Stage IV Breast Cancer AJCC v8
- Breast Carcinoma
- Metastatic Breast Carcinoma
- Prognostic Stage IV Breast Cancer AJCC v8
- Recurrent Breast Carcinoma
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Informational Intervention | Receive standard chemotherapy educational materials |
| OTHER | Informational Intervention | Receive personalized information about cancer, treatment, and side effects |
| OTHER | Quality-of-Life Assessment | Ancillary studies |
| OTHER | Survey Administration | Complete surveys |
Timeline
- Start date
- 2019-02-06
- Primary completion
- 2022-08-30
- Completion
- 2022-08-30
- First posted
- 2020-03-05
- Last updated
- 2023-04-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04297384. Inclusion in this directory is not an endorsement.